Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single-dose challenges

Continuous subcutaneous (SC) infusion of the dopamine agonist apomorphine was shown in retrospective studies to improve drug‐induced dyskinesias in Parkinson's disease (PD). We prospectively assessed the antidyskinetic effect of continuous SC apomorphine therapy using subjective and objective m...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Movement disorders 2005-02, Vol.20 (2), p.151-157
Hauptverfasser:	Katzenschlager, Regina, Hughes, Andrew, Evans, Andrew, Manson, Alice J., Hoffman, Marion, Swinn, Lesley, Watt, Hilary, Bhatia, Kailash, Quinn, Niall, Lees, Andrew J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Antiparkinson Agents - therapeutic use apomorphine Apomorphine - therapeutic use Biological and medical sciences Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Dose-Response Relationship, Drug Drug Administration Schedule Drug toxicity and drugs side effects treatment dyskinesias Dyskinesias - drug therapy Dyskinesias - etiology Female Follow-Up Studies Humans Injections, Subcutaneous Levodopa - therapeutic use Male Medical sciences Middle Aged Neurologic Examination Neurology Pain Measurement - methods Parkinson Disease - complications Parkinson's disease Pharmacology. Drug treatments Prospective Studies Self-Assessment Statistics, Nonparametric Toxicity: nervous system and muscle
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!